T1	Participants 624 771	The second study assessed the effects of GH (2 IU/day) on lipid oxidation and on protein metabolism using the whole body leucine turnover technique
T2	Participants 438 623	The first study assessed the effects of incremental doses of GH (0.5, 1.0, 2.0 IU/day for 1 wk each) on insulin-like growth factor I (IGF-I) levels during each estrogen treatment phase.
T3	Participants 271 437	In two separate studies, eight GHD women randomly received either oral or transdermal estrogen for 8 wk before crossing over to the alternate route of administration.
T4	Participants 1458 1534	Estrogen replacement in GHD women should be administered by a nonoral route.
